Zevra Therapeutics (ZVRA) Earnings Analysis
Zevra Therapeutics (ZVRA) has no confirmed upcoming earnings date. Last quarter (2026-03-09) it beat with EPS 1.16 USD vs 0.0504 USD est (+2201.6%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 5.57.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ZVRA next report earnings?
No confirmed upcoming earnings date is currently scheduled for ZVRA. This page updates as the calendar is published.
ZVRA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-09 | 1.16 USD | 0.0504 USD | +2201.6% | Beat |
| 2025-08-12 | 1.21 USD | 2.19 USD | -44.7% | Miss |
| 2025-03-11 | -0.67 USD | -0.39 USD | -71.8% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
ZVRA valuation and analyst view
| Trailing P/E | 5.57 |
|---|---|
| Trailing EPS | 2.127 USD |
| Price / book | 3.45 |
| Dividend yield | 0.00% |
| Market cap | 0.72B |
| Analyst consensus | Buy (10 buy / 0 hold / 0 sell) |
| Avg price target | 29.5 USD |
Related research pages
Frequently asked questions
When is Zevra Therapeutics (ZVRA)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ZVRA. This page updates as the calendar is published.
Did ZVRA beat earnings last quarter?
In its 2026-03-09 report, ZVRA posted EPS of 1.16 USD versus a 0.0504 USD estimate — a beat of 2201.6%.
What is ZVRA's earnings track record?
Over the last 3 reported quarters with consensus data, ZVRA beat estimates 1 times (33%).
What is ZVRA's current P/E ratio and EPS?
ZVRA trades at a trailing P/E of 5.57 on trailing EPS of 2.1268036795220624 USD.
What do analysts rate ZVRA?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 29.5 USD.